| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 01/04/2007 | US20070003629 Anticancer agents; prevent forming blood vessels; removal blockage |
| 01/04/2007 | US20070003627 Hemorrhoidal compositions and method of use |
| 01/04/2007 | US20070003578 Chimeric protein comprising non-toxic pseudomonas exotoxin and type IV pilin sequences |
| 01/04/2007 | US20070003544 Combination therapy for treatment of autoimmune diseases using b- cell depleting/immunoregulatory antibody combination |
| 01/04/2007 | US20070003524 Targeted retrograde gene delivery to motor neurons |
| 01/04/2007 | DE202006012481U1 Composition for treating or preventing cardiovascular diseases, especially atherosclerosis, comprises folate |
| 01/04/2007 | CA2613703A1 Abca1 elevating compounds |
| 01/04/2007 | CA2613477A1 Thiol-sensitive positive inotropes |
| 01/04/2007 | CA2612601A1 Heteroaryl-substituted amides comprising an unsaturated or cyclic linker group, and their use as pharmaceuticals |
| 01/04/2007 | CA2611953A1 Heteroaryl-substituted amides comprising a saturated linker group, and their use as pharmaceuticals |
| 01/04/2007 | CA2611296A1 Pyrazolopyridine derivatives as inhibitors of beta-adrenergic receptor kinase 1 |
| 01/04/2007 | CA2610074A1 6-oxazol-4-ylmethoxy-alkoxymethyl substituted benzoic acid derivatives forming ppar ligands, methods for production and the use thereof in the form of drugs |
| 01/03/2007 | EP1739090A2 Interferon-beta fusion proteins and uses |
| 01/03/2007 | EP1739087A1 Pyrazole compositions useful as inhibitors of gsk-3 |
| 01/03/2007 | EP1739081A1 Hydrazino-substituted heterocyclic nitrile compounds and use thereof |
| 01/03/2007 | EP1738762A1 Preventive/remedy for diabetic complications using oligopeptide |
| 01/03/2007 | EP1738757A1 Prevention of secondary stroke with cholesterol lowering agents |
| 01/03/2007 | EP1738756A2 Esmolol formulation |
| 01/03/2007 | EP1738755A1 Tablet containing branched chain amino acid and process for producing the same |
| 01/03/2007 | EP1738754A1 Solid pharmaceutical preparation |
| 01/03/2007 | EP1737949A2 Endothelial progenitor cells and methods of use thereof |
| 01/03/2007 | EP1737948A2 Methods of promoting cardiac cell proliferation |
| 01/03/2007 | EP1737888A2 Erythropoietin protein variants |
| 01/03/2007 | EP1737852A2 Polycyclic pyridines as potassium ion channel modulators |
| 01/03/2007 | EP1737847A2 Nebivolol and its pharmaceutically acceptable salts, process for preparation and pharmaceutical compositions of nebivolol |
| 01/03/2007 | EP1737811A1 Cetp inhibitors |
| 01/03/2007 | EP1737490A2 Methods of treating autoimmune and inflammatory diseases |
| 01/03/2007 | EP1737448A1 (s) - enoximone sulfoxide and its use in the treatment of pde-iii mediated diseases |
| 01/03/2007 | EP1737447A1 (r)-enoximone sulfoxide and its use in the treatment of pde-iii mediated diseases |
| 01/03/2007 | EP1463487A4 Liposomal delivery of vitamin e based compounds |
| 01/03/2007 | EP1401450B1 Use of a pyridazinone derivative for the treatment of congestive heart failure |
| 01/03/2007 | EP1390403B1 Peptides derived from neural thread proteins and their medical use |
| 01/03/2007 | EP1362601B1 Method of examining effect of angionegesis inhibitor mediated by the inhibition of integrin expression |
| 01/03/2007 | EP1347780B1 Compositions of n-(methylethylaminocarbonyl)-4-(3-methylphenylamino)-3-pyridylsulfonamide and cyclic oligosaccharides |
| 01/03/2007 | EP1322176B1 Use of carnitine for enhancing training-induced bradycardia |
| 01/03/2007 | EP1057489B1 Use of midkine family proteins in the treatment of ischemic diseases |
| 01/03/2007 | EP1024794B1 Methods of treating capsules and dry, powdered pharmaceutical formulations |
| 01/03/2007 | EP0526452B2 Hybrid immunoglobulins |
| 01/03/2007 | CN1890240A Diazabicyclononene derivatives and their use as renin inhibitors |
| 01/03/2007 | CN1890239A Azabicyclooctene and other tetrahydropyridine derivatives with a new side-chain |
| 01/03/2007 | CN1890238A Hydronopol derivatives as agonists on human ORL1 receptors |
| 01/03/2007 | CN1890220A A crystalline of the salt form of 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7-methoxy-6-quinolinecarboxamide or the solvate of the salt and a process for preparing the same |
| 01/03/2007 | CN1890214A Heterocyclic- or aryloxy, -thio or -amino substituted indoles-2-carboxylic acids or esters as pai-1 |
| 01/03/2007 | CN1887894A Extraction and application of anthraglucorhein and rhubarb aglycone |
| 01/03/2007 | CN1887882A Dextro lipoic amidate and its prepn |
| 01/03/2007 | CN1887837A Extraction process and application of emodin and aloe-emodin |
| 01/03/2007 | CN1887347A Prepn technology of antithrombotic hirudin aerosol |
| 01/03/2007 | CN1887307A Medicine composition for treating chronic heart failure and hypotension and its prepn and use |
| 01/03/2007 | CN1887289A Oral disintegrant tablet of total arasaponin and its prepn |
| 01/03/2007 | CN1887284A Medicine composition of trifusal and clopidogrel |
| 01/03/2007 | CN1887283A Medicine composition containing bailobalide |
| 01/03/2007 | CN1887282A Medicine composition containing bailobalide |
| 01/03/2007 | CN1887278A Slow released doxazosin mesilate capsule and its prepn process |
| 01/03/2007 | CN1293080C Process for the preparation of clopidogrel |
| 01/03/2007 | CN1293076C Activator for peroxisome proliferator-activated receptor delta |
| 01/03/2007 | CN1293074C Arylindenopyridines with PDE inhibiting activity |
| 01/03/2007 | CN1293064C Deuterated 3-piperidinopropiophenone and medicaments containing said compounds |
| 01/03/2007 | CN1293063C Substituted heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them |
| 01/03/2007 | CN1293059C New Carboxglic acid derivative, its preparation and application |
| 01/03/2007 | CN1293055C Piperidine derivative crystal, midbody for preparation and preparing method |
| 01/03/2007 | CN1293049C N-hydroxyformamidine derivative |
| 01/03/2007 | CN1293044C Substituted phenypropionic acid derivatives as agonists to human peroxisome proliferator-activated receptor alpha (PPAR) |
| 01/03/2007 | CN1292786C Method for preparing Chinese medicine composition for treating ischemic brain apoplexy |
| 01/03/2007 | CN1292776C Medicine for treating facial hemiparalysis disease |
| 01/03/2007 | CN1292769C Chinese medicine for preventing and treating atherosclerosis and its preparing method |
| 01/03/2007 | CN1292766C Chinese medicinal preparation for treating viral myocarditis and its making method |
| 01/03/2007 | CN1292747C Compound formulation for treating hypertension |
| 01/03/2007 | CN1292736C Dripping pill made from haw, chrysanthemum and Chinese wolfberry fruit and its preparing method |
| 01/02/2007 | US7157604 Selective estrogen receptor modulators |
| 01/02/2007 | US7157584 Benzimidazole derivative and use thereof |
| 01/02/2007 | US7157578 4-(2-butylamino)-2, 7-dimethyl-8-(2-methyl-6-methoxypyrid-3-YL) pyrazolo-[1,5-A]-1,3,5-triazine, its enantiomers and pharmaceutically acceptable salts as corticotropin releasing factor receptor ligands |
| 01/02/2007 | US7157500 Nitrosylation of protein SH groups and amino acid residues as a therapeutic modality |
| 01/02/2007 | US7157496 Feeds, beverages, foods, health food supplements |
| 01/02/2007 | US7157483 Imidazole derivatives modulating the sodium channels |
| 01/02/2007 | US7157479 Oxazol/thiazol-derivatives activators of the hPPAR-alpha receptor |
| 01/02/2007 | US7157472 N-alkylpiperdino-4-yl-urea-pyrazole derivative for treating obesity, metabolic disorders, eating disorders and diabetes |
| 01/02/2007 | US7157469 For therapy of immune related responses, tumor growth, glomerulonephritis, inflammation, malarial anemia, septic shock, tumor associated angiogenesis, vitreoretinopathy, psoriasis, graft versus host disease, atopic dermatitis |
| 01/02/2007 | US7157457 Compounds useful in the treatment of inflammatory diseases |
| 01/02/2007 | US7157456 Anticoagulates for treating cardiovascular disorders, such as myocardial infarct, angina pectoris, restenoses after angioplasty, bypass, stroke; treatment of atherosclerosis, arthritis, Alzheimer's disease or cancer |
| 01/02/2007 | US7157454 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same |
| 01/02/2007 | US7157451 Cardiac arrhythmias; potassium channel function inhibitors; such as 7-(3,4-Dichlorophenyl)-6-(5-fluoro-1-methyl-1H-benzimidazol-2-yl)-4,7 -dihydro-5-(methoxymethyl)pyrazolo-(1,5-a)pyrimidine |
| 01/02/2007 | US7157433 Compounds, compositions as carriers for steroid/nonsteroid anti-inflammatory; antienoplastic and antiviral active molecules |
| 01/02/2007 | US7157425 Apolipoprotein agonist for use in the treatment of dyslipidemia |
| 01/02/2007 | US7157423 Using fumaric acid mono- and diamides, or monoamido fumaric acid monoesters for therapy of an autoimmune disease; transplantation medicine; therapy of mitochondrial diseases, for therapy of NF-kappaB mediated diseases |
| 01/02/2007 | US7157420 Therapeutic agents and methods of use thereof for the modulation of angiogenesis |
| 01/02/2007 | US7157243 DNA encoding mammalian T-type calcium channels |
| 01/02/2007 | US7157241 Dipeptidyl peptidase IV (DPPIV); given sequences; homology with family of prolyl oligopeptidases; drug screening for enzyme inhibitors for DPPIV which could treat reproductive, inflammatory and metabolic disorders |
| 01/02/2007 | US7157240 MID 4460, a human tyrosine phosphatase family member and uses therefor |
| 01/02/2007 | US7157101 Micronized eplerenone compositions |
| 01/02/2007 | US7157086 Treatment of specific and non-specific inflammation, including asthma; useful in diagnosing and localizing sites of inflammation. |
| 01/02/2007 | US7157082 Cardioprotective therapies based on enzymatic elimination of lipid peroxides by allene oxide synthase |
| 01/02/2007 | CA2412170C Uses of thaliporphine or its derivatives in treatment of cardiac diseases and preparation of same |
| 01/02/2007 | CA2376668C Naphthyridine derivatives, processes for their preparation, their use and pharmaceutical compositions comprising them |
| 01/02/2007 | CA2373999C Pyrazinone thrombin inhibitors |
| 01/02/2007 | CA2352361C Pharmaceutical combination preparations of carvedilol and hydrochlorothiazide and the process for their preparation |
| 01/02/2007 | CA2344350C 4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines |
| 01/02/2007 | CA2274464C Ketobenzamides as calpain inhibitors |
| 01/02/2007 | CA2191454C Phosphinic acid derivatives and their use as endothelin converting enzyme inhibitors |
| 01/02/2007 | CA2174517C Receptor specific atrial natriuretic peptides |
| 12/28/2006 | WO2006138266A2 The preparation and use of compounds as aspartyl protease inhibitors |